by James Rudge, PhD, Technical Director, Neoteryx | 8 min read
An article published by Nils T. Vethe et al in the October 2019 issue of Therapeutic Drug Monitoring, reported on the successful validation of 10 µL Mitra® devices from 26-27 …
Read Storyby Neoteryx | 5 min read
According to a 2014 study, the cost of developing a new drug is $2.6 billion. This high expense doesn’t include the additional cost of post-approval development to determine dosage strengths …
Read Storyby Neoteryx | 2 min read
Therapeutic drug monitoring (TDM) helps in managing patients who are undergoing psycho-pharmacotherapy. TDM is essential in preventing therapeutic nonresponse and adverse drug reactions. It also enables dose adjustment, determination of …
Read Storyby Neoteryx | 3 min read
Just like every other industry, the healthcare sector continues to experience drastic changes. With each new year, it helps to identify the trends that are likely to shape the industry …
Read Storyby Neoteryx | 5 min read
Times have changed, and so has the average healthcare consumer. Today’s consumers are more inclined toward digital health solutions, particularly the younger generations. A survey from Accenture found millennials (born …
Read Storyby Neoteryx | 4 min read
What is occupational exposure? Millions of people are exposed to chemicals or other hazardous materials in their workplace every day. If not handled safely, these hazards can cause health problems …
Read Story